Revolution Medicines Inc (RVMD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RVMD Annual Balance Sheets →
Quarterly balance sheet trends provide context on Revolution Medicines Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent815.44
Marketable Securities, Current SH3,122.53
Cash & Short-term Investments3,937.00
Prepaid Expense And Other Assets Current90.37
Total Current Assets4,028.34
Equipment/Property/Plant Net67.45
Goodwill net14.61
Intangible Assets55.80
Deposits Assets, Noncurrent AS42.45
Other Assets, Noncurrent114.62
Operating Lease Right Of Use Asset129.90
Restricted Cash Noncurrent4.86
Total Assets4,323.27
Liabilities
Accounts Payable, Current AC88.42
Accrued Royalties622.17
Total Current Liabilities354.06
Long-term Debt Convertible487.43
Total Long-term Debt487.43
Other liabilities, Noncurrent519.01
Accrued Expenses And Other Current Liabilities192.45
Operating Lease Liability Current16.61
Warrant Liability34.33
Deferred Income Tax Liabilities Net2.35
Operating Lease Liability Noncurrent140.02
Total Liabilities1,717.03
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock6,579.46
Retained Earnings / Accumulated Deficit-3,967.29
Accumulated Other Comprehensive Income-5.95
Other Equity-5.95
Common Stockholder's Equity2,606.24
Total Stockholder's Equity2,606.24
Liabilities & Stockholder's Equity4,323.27
4 historic quarters locked

Sign in to unlock the full Revolution Medicines Inc balance sheet history.

About Revolution Medicines Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-335104

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.